Thorax-, hjerte- og karkirurgi
Præoperativ anæmibehandling og optimering af erytrocytmasse
Ferric carboxymaltose in patients with heart failure and iron deficiency. (åbner nyt vindue)
Kilde: N Engl J Med 2009;361(25):2436-48.
Indekseret: PubMed 19920054
DOI: 10.1056/NEJMoa0908355
https://www.ncbi.nlm.nih.gov/pubmed/19920054 (åbner nyt vindue)
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (åbner nyt vindue)
Kilde: Vasc Endovascular Surg 2007;41(5):460-2.
Indekseret: PubMed 17942864
DOI: 10.1177/1538574407303172
https://www.ncbi.nlm.nih.gov/pubmed/17942864 (åbner nyt vindue)
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (åbner nyt vindue)
Kilde: Catheter Cardiovasc Interv 2014;83(6):E221-6.
Indekseret: PubMed 24402965
DOI: 10.1002/ccd.25389
https://www.ncbi.nlm.nih.gov/pubmed/24402965 (åbner nyt vindue)
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (åbner nyt vindue)
Kilde: Anesth Analg 2019;128(5):981-92.
Indekseret: PubMed 30649068
DOI: 10.1213/ANE.0000000000004005
https://www.ncbi.nlm.nih.gov/pubmed/30649068 (åbner nyt vindue)
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (åbner nyt vindue)
Kilde: Can J Cardiol 2014;30(Suppl):S234.
DOI: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (åbner nyt vindue)
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (åbner nyt vindue)
Kilde: Am J Cardiol 2012;110(7):1021-6.
Indekseret: PubMed 22771376
DOI: 10.1016/j.amjcard.2012.05.036
https://www.ncbi.nlm.nih.gov/pubmed/22771376 (åbner nyt vindue)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (åbner nyt vindue)
Kilde: Eur J Heart Fail 2013;15(11):1267-76.
Indekseret: PubMed 23787722
DOI: 10.1093/eurjhf/hft099
https://www.ncbi.nlm.nih.gov/pubmed/23787722 (åbner nyt vindue)
Current status of pharmacologic therapies in patient blood management. (åbner nyt vindue)
Kilde: Anesth Analg 2013;116(1):15-34.
Indekseret: PubMed 23223098
DOI: 10.1213/ANE.0b013e318273f4ae
https://www.ncbi.nlm.nih.gov/pubmed/23223098 (åbner nyt vindue)
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (åbner nyt vindue)
Kilde: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
Indekseret: PubMed 26809765
DOI: 10.1053/j.jvca.2015.10.021
https://www.ncbi.nlm.nih.gov/pubmed/26809765 (åbner nyt vindue)
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (åbner nyt vindue)
Kilde: Transfusion 2008;48(4):666-72.
Indekseret: PubMed 18194382
DOI: 10.1111/j.1537-2995.2007.01590.x
https://www.ncbi.nlm.nih.gov/pubmed/18194382 (åbner nyt vindue)
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (åbner nyt vindue)
Kilde: Br J Anaesth. 2022;128(5):796-805.
Indekseret: PubMed 35256150
DOI: 10.1016/j.bja.2022.01.034
https://pubmed.ncbi.nlm.nih.gov/35256150/ (åbner nyt vindue)
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (åbner nyt vindue)
Kilde: Transfus Med Rev 2013;27(4):221-34.
Indekseret: PubMed 24135037
DOI: 10.1016/j.tmrv.2013.09.001
https://www.ncbi.nlm.nih.gov/pubmed/24135037 (åbner nyt vindue)
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (åbner nyt vindue)
Kilde: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
Indekseret: PubMed 23998782
DOI: 10.1016/j.jtcvs.2013.06.033
https://www.ncbi.nlm.nih.gov/pubmed/23998782 (åbner nyt vindue)
Jehovah's Witnesses and cardiac surgery: a single institution's experience. (åbner nyt vindue)
Kilde: Transfusion 2014;54(10 Pt 2):2745-52.
Indekseret: PubMed 24809815
DOI: 10.1111/trf.12696
https://www.ncbi.nlm.nih.gov/pubmed/24809815 (åbner nyt vindue)
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (åbner nyt vindue)
Kilde: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
Indekseret: PubMed 33483268
DOI: 10.1053/j.jvca.2020.12.044
https://pubmed.ncbi.nlm.nih.gov/33483268/ (åbner nyt vindue)
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (åbner nyt vindue)
Kilde: Surg Infect (Larchmt) 2009;10(1):9-19.
Indekseret: PubMed 19245362
DOI: 10.1089/sur.2008.043
https://www.ncbi.nlm.nih.gov/pubmed/19245362 (åbner nyt vindue)
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (åbner nyt vindue)
Kilde: Anaesthesia 2020;75(8):1039-49.
Indekseret: PubMed 32342498
DOI: 10.1111/anae.15062
https://www.ncbi.nlm.nih.gov/pubmed/32342498 (åbner nyt vindue)
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (åbner nyt vindue)
Kilde: J Vasc Surg 2003;37(2):453-5.
Indekseret: PubMed 12563221
DOI: 10.1067/mva.2003.73
https://www.ncbi.nlm.nih.gov/pubmed/12563221 (åbner nyt vindue)
Intravenous iron in heart failure: beyond targeting anemia. (åbner nyt vindue)
Kilde: Curr Heart Fail Rep 2011;8(1):14-21.
Indekseret: PubMed 21057903
DOI: 10.1007/s11897-010-0034-4
https://www.ncbi.nlm.nih.gov/pubmed/21057903 (åbner nyt vindue)
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (åbner nyt vindue)
Kilde: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
Indekseret: PubMed 26211405
DOI: 10.1016/j.jtcvs.2015.06.059
https://www.ncbi.nlm.nih.gov/pubmed/26211405 (åbner nyt vindue)
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (åbner nyt vindue)
Kilde: J Nephrol 2008;21(2):236-42.
Indekseret: PubMed 18446719
https://www.ncbi.nlm.nih.gov/pubmed/18446719 (åbner nyt vindue)
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (åbner nyt vindue)
Kilde: J Thorac Cardiovasc Surg 2010;139(3):621-7.
Indekseret: PubMed 20042202
DOI: 10.1016/j.jtcvs.2009.10.012
https://www.ncbi.nlm.nih.gov/pubmed/20042202 (åbner nyt vindue)
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (åbner nyt vindue)
Kilde: Transfusion 2015;55(7):1644-54.
Indekseret: PubMed 25702777
DOI: 10.1111/trf.13027
https://www.ncbi.nlm.nih.gov/pubmed/25702777 (åbner nyt vindue)
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (åbner nyt vindue)
Kilde: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
Indekseret: PubMed 25847415
DOI: 10.1053/j.jvca.2014.10.022
https://www.ncbi.nlm.nih.gov/pubmed/25847415 (åbner nyt vindue)
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (åbner nyt vindue)
Kilde: Anesthesiology 2011;115(5):929-37.
Indekseret: PubMed 22027622
DOI: 10.1097/ALN.0b013e318232004b
https://www.ncbi.nlm.nih.gov/pubmed/22027622 (åbner nyt vindue)